Sort   by:  
 Page size 
UnknownNALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.
Not available
S-EPMC12913728 | biostudies-literature
ProteomicsMass Spectrometry analysis of potential proteins interacting with cyclin D1 mutants (T286A or T288A)
Co-IP assays and Proteomics were performed to identify potential E3 ligases interacted with both cyclin D1 T286A and cyclin D1 T288A.
ORGANISM(S): Homo Sapiens 
2024-05-17 | PXD052332 |
Sort   by:  
 Page size